Creative Planning Nektar Therapeutics Transaction History

Creative Planning

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 01, 2019	SELL	$16.91 - $36.27 $157,076 - $336,912	-9,289 Closed	0 $0
Q2 2019 Jul 26, 2019	SELL	$31.0 - $36.3 $47,058 - $55,103	-1,518 Reduced 14.05%	9,289 $331,000
Q4 2018 Feb 01, 2019	BUY	$30.43 - $56.65 $1,186 - $2,209	39 Added 0.36%	10,807 $355,000
Q3 2018 Oct 25, 2018	BUY	$46.46 - $68.49 $87,577 - $129,103	1,885 Added 21.22%	10,768 $656,000
Q2 2018 Jul 20, 2018	BUY	$46.25 - $104.45 $230,602 - $520,787	4,986 Added 127.94%	8,883 $434,000

Q1 2018 Apr 18, 2018	BUY	$57.4 - $108.44 $223,687 - $422,590	3,897 New	3,897 $414,000

126

109M

150K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $259M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.